PHS33 Cost Analysis of Dialysis Practice in Turkey  by Tatar, M. et al.
burden is important in informing health care planning and policy development.
This study was conducted to describe the NHS costs associated with AF manage-
ment in routine UK clinical practice. METHODS: A retrospective observational
study of 825 patients with AF was undertaken in 8 UK primary care practices in
2010. Data were collected from the clinical records of all eligible, consenting pa-
tients, for a period of up to 3 years. The first 12 weeks following diagnosis was
defined as the ‘initiation phase’; the period after week 12 was defined as the ‘main-
tenance phase’.RESULTS:Mean (SD) total cost of AF management was £947/€1,153/
1,476USD (£1,098/€1,337/$1,711) per patient in the initiation phase and £469/€571/
$731 (£597/€727/$930) per patient year in the maintenance phase. Inpatient
admissions and secondary care attendances accounted for 83% of total initiation
phase and 64% of total maintenance phase costs. Significant variables contributing
to high cost in the initiation phase were co-morbid hypertension and lower patient
age, although only accounting for 5% of cost variability. Significant variables in the
maintenance phase (18% of cost variability) were co-morbid congestive or struc-
tural heart disease and diabetes, and day-care attendances, ECGs and hospitalisa-
tions in the initiation phase. Mean maintenance phase costs were higher for pa-
tients managed by practices providing anticoagulation services (£555/€676/$865)
than patients receiving secondary care anticoagulation (£421/€513/$656, p0.002).
CONCLUSIONS: The study confirms that inpatient admissions and secondary care
attendances contribute most to total AF management costs. None of the variables
analysed accounted for much variability in the total cost of AF management, sug-
gesting that it is often not possible to predict which patients will be high NHS
resource users. Future work should focus on how to safely reduce avoidable hos-
pital admissions.
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OBJECTIVES: Studies estimating the cost of treating patients suffering from the
Obstructive Sleep Apnea/Hypopnea Syndrome (OSAHS) have not been conducted
in Greece. The aim of this study was to investigate the annual cost of patients with
OSAHS and identify the potential economic burden to the patients treated.
METHODS: A retrospective study was conducted in the sleep laboratory of Sotiria
Chest Hospital in Athens from January 1, 2008 to December 31, 2008. A sample of
340 subjects was screened for OSAHS. Diagnosis was confirmed after polysomnog-
raphy. Health resources’ consumption was derived from patients’ analytical re-
cords, the annual visits in the sleep laboratory and the purchase of the ventilation
devices (CPAP, BiPAP). Outpatient visits’ costs included labor costs, overheads, con-
sumables related to the OSAHS patients. The bottom-up approach and the pa-
tients’ perspective have been used. RESULTS: A total of 262 males and 78 females,
mean aged 55,9 (SD12,4) years participated in this study. Overall mean annual
cost reaches approximately €1.685,90 per patient out of which 15% is paid by NHS,
64% by social funds and 21% by patients’ out-of-pocket payments. The major cost
driver is devices’ purchase (66.55%). Patients’ out of pocket spending for the pur-
chase of the BiPAP ranges from 5% to 48.6% and of the CPAP from 0% to 33.5%
depending on the social fund in which the patient belongs. CONCLUSIONS: Varia-
tions are found among patients’ social insurance coverage related to the purchase
of both devices as well as severe inequalities in patients’ cost sharing among the
various funds. Further research is needed in similar sleep laboratories in Greece.
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OBJECTIVES: To describe health care costs associated with the management of PsA
in patients newly initiated on a biologic DMARD or MTX.METHODS:Adult patients
with 2 PsA diagnosis (from office visits), continuously enrolled 6-month pre-
and12-month post-index date (i.e., first biologic DMARD/MTX prescription date),
and no diagnosis for ankylosing spondylitis were selected from the MarketScan
Commercial Claims database (2005-2009). MTX initiators were required to be both
biologic and non-biologic DMARD naïve prior to index date. Biologic initiators were
required to be biologic-naïve only prior to index date. All-cause and PsA-related
total health care costs were estimated during the 12-month study period from a
payer perspective (2011 USD). PsA-related medical cost was defined as costs asso-
ciated with a claim with a PsA diagnosis or with DMARD administration by health
care professionals. Office care and monitoring costs were defined as the sum of
PsA-related outpatient and other medical services costs (excluding costs for drugs
administration). Urgent care costs were defined as the sum of inpatient and emer-
gency room costs. PsA-related pharmacy costs were defined as the sum of biologic
and non-biologic DMARD costs. RESULTS: A total of 1,217 MTX initiators and 3,263
biologic initiators met the eligibility criteria. MTX initiators had an average annual
total health care cost of $14,329 where $6,065 were PsA-related. Pharmacy costs
accounted for 80.4% of total PsA-related costs; office care and monitoring costs for
16.3%; urgent care costs for 3.3%. Biologic initiators had an average annual total
health care cost of $30,282 and 67.5% were PsA-related. Pharmacy costs accounted
for 92.7% of PsA-related total costs; office care and monitoring cost for 5.1%; urgent
care cost for 2.3%. CONCLUSIONS: PsA patients initiating a DMARD incurred sub-
stantial health care costs. Although pharmacy costs accounted for most of the
PsA-related costs, office care and monitoring costs represented a significant part of
the PsA-related costs.
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OBJECTIVES: To evaluate the most frequent outpatient care physiotherapy ser-
vices provided for musculoskeletal and connective tissue diseases and determine
the total health care expenses of them. METHODS: Data were derived from the
countrywide database of Hungarian Health Insurance Administration (HHIA),
based on official reports of outpatient care institutes in 2008. The total numbers of
different physiotherapy services were determined by selecting the reported spe-
cific diagnoses codes and counting the number treatments provided for that spe-
cific diagnosis code. The different types of treatment codes are listed in the chapter
of the Guidelines of HHIA for ‘Physiotherapists, massage-therapists, conductors
and other physiotherapy practices‘. The musculoskeletal and connective tissue
diseases are listed in the International Classification of Diseases (ICD) with code of
M00-M99. RESULTS: The total number of the 151 different types WHO-classified
physiotherapy services was 29045736 in the year of 2008, 17455468 (60.1%) of them
with the ICD code group M00-M99. The services with highest incidence are the
followings: 1) ultrasound therapy 2011189 (11.52%); 2.) iontophoresis 1586016
(9.08%); 3) massage therapy with hand l946364 (5.42%); 4) middle frequency elec-
trotherapy 932474 (5.34%); and 5) passive motion therapy on multiple limbs 821314
(4.7%). The number of the 20 most frequent types of therapies was 14285957, which
is the 81.84% of all cases. The total health insurance reimbursement of the treat-
ments of diseases with ICD code M00-M99 was 4.713 billion Hungarian Forint (18.76
million EUR). CONCLUSIONS: The 60.1% of the total number of physiotherapy ser-
vices were provided for the treatments of diseases with ICD code M00-M99, sup-
porting the notion that physiotherapy is dominantly used in the treatment mus-
culoskeletal diseases. The financial cost of the outpatient care physiotherapy of
diseases with ICD code M00-M99 exceeded the 50% of the total budget provided for
physiotherapy services.
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OBJECTIVES: To evaluate the most frequent outpatient care physiotherapy ser-
vices provided for trauma patients and determine the total health care expenses of
them. METHODS: Data were derived from the countrywide database of Hungarian
Health Insurance Administration (HHIA), based on official reports of outpatient
care institutes in 2008. The total numbers of different physiotherapy services were
determined by selecting the reported specific diagnoses codes and counting the
number treatments provided for that specific diagnosis code. The different types of
treatment codes are listed in the chapter of the Guidelines of HHIA for ‘Physiother-
apists, massage-therapists, conductors and other physiotherapy practices’. The
injuries caused by trauma are listed among with all type of injuries, poisoning and
other external mechanisms in the International Classification of Diseases (ICD)
code group of S00-T98. RESULTS: The total number of the 151 different types WHO-
classified physiotherapy services was 29045736 in the year of 2008; 3188650 of them
with the ICD code group S00-S99. The services with the highest incidence are the
followings: 1) individual physiotherapy 352406 (11.15%), 2) muscle strengthening
exercises 251398 (7.88%), 3) stretching of contractures 247442 (7.76%), 4. circulation
enhancing physiotherapy 230930 (7.24%) and 5) exercises against resistance 210703
(6.61%). Of all body regions, the knee and the lower leg demanded the highest
number of treatments (22.4%), followed with the shoulder (22.31%), elbow (18.7%)
and wrist (14.18%); while the lowest number of services was required after the head
(1.71%) and neck (0.67%) traumas. The total health insurance reimbursement of
diseases with ICD code S00-S99 was 962 million Hungarian Forint (3.829 million
EUR). CONCLUSIONS: The number of treatments accompanied diseases with ICD
code S00-S99 in the year of 2008 shows a relatively low percentage (11%) of all
physiotherapy services.
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OBJECTIVES: End stage renal failure is expected to become a major health problem
for Turkey due to aging population and the increasing incidence of chronic diseases
with renal effects. It was reported that end stage renal failure incidence with a need
for transplantation has risen from 350 to 847 per million population from 1998 to
2009. In addition, the number of patients needing dialysis treatment has also risen
from 3069 to 46659 for the same years. Dialysis treatment is predominantly in
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private sector in Turkey and as of 2009, 71.5% of total dialysis treatment was ad-
ministered by the private sector. The aim of the study is to calculate the average
cost of dialysis seance for Turkey. METHODS: A Cost model was designed with
main costs including pharmaceutical, medical device, personal, financial, depreci-
ation, tax and other cost. 75 dialysis clinics, already audited by international inde-
pendent organizations, were included in the analysis. RESULTS: A total of 7.102
and 7.090 patients were treated, 1.018.712 and 1.028.392 seances were adminis-
tered in the selected clinics in 2009 and 2010, respectively. The total costs were
calculated as 166 million TL and 163 million TL in 2009 and 2010. Personel costs had
the highest share (35.14% and 35.90%) followed by pharmaceutical and medical
device costs ( 27.16% and 26.20%) for 2009 and 2010, respectively. Average seance
costs were calculated as 163.40 TL and 164.07 TL for 2009 and 2010. CONCLUSIONS:
The Social Security Institution reimburses 135 or 145 TL per dialysis seance de-
pending on the treatment. However, as the study results show this reimbursement
rate is below the real cost. This may cause dialysis center‘s not to provide health
care for government reimbursement agency or going to close due the financial
diffuculties. Closing of private centers may efect system especially patients, be-
cause of dialysis treatment was administered mostly by private sector.
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OBJECTIVES: While it is targeted to give the best health care to patients in emer-
gency room (ER), the economic consequences of the management approach should
also be considered seriously. In this report, the comparison between weekdays and
weekends, of the cost of management of the most common cardiovascular reasons
for admission to ER is presented.METHODS:The invoices generated for admissions
within years 2009-2011, to ER with the presenting diagnoses of (1) hypertensive
diseases, (2) heart failure or (3) cerebrovascular diseases were reviewed. Invoices
were prepared in Turkish Liras (TL). Mid-year TL/€ conversion rates were used
(2.1567, 1.9494 and 2.3435 TL/€ in 2009, 2010 and 2011, respectively). The analysis
was performed form the payer’s perspective. RESULTS: For patients with hyper-
tensive diseases (n18,372), average total cost of health care on Saturdays and
Sundays was 15.92€. This figure was 9.6% and 6.9% higher than the total cost on
Monday and the average total cost on weekdays, respectively. The cost of proce-
dures on weekend was 14.69€. This was 8.4% and 4.0% higher than the cost on
Monday and than the average cost on weekdays, respectively. Average cost of
medications on weekend was 1.00€. This was 16.7% and 48.0% higher than the cost
on Monday and than the average cost on weekdays, respectively. Total costs on
weekends were also higher than on Mondays (and weekdays average) in other
diseases; 46% (38%) for heart failure and 5% (3%) for cerebrovascular diseases.
CONCLUSIONS: The cost of management was higher on weekends than weekdays
for cardiovascular diseases with different nature of courses. Therefore we suggest
that this amount of change in cost in ER is not related with the clinical parameters.
The reason for this high weekend cost might be inappropriate use of health care on
weekends, because the support and supervision of the multidisciplinary approach
are weakened on weekends.
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OBJECTIVES: To evaluate the activity of the outpatient care physiotherapy services
in Hungary, according to the International Classification of Diseases (ICD) code
system. METHODS: Data were derived from the countrywide database of Hungar-
ian Health Insurance Administration (HHIA), based on official reports of outpatient
care institutes in 2008. The total number and the distribution of physiotherapy
services were evaluated according to all of 21 ICD code groups for the year 2008. The
different types of treatment codes are listed in the chapter of the Guidelines of
HHIA for ‘Physiotherapists, massage-therapists, conductors and other physiother-
apy practices’. RESULTS: The total number of physiotherapy services provided in
2008 was 28943680 interventions, of which the 20 most frequent treatments ac-
counts for 72.03 % (20848928) of total services. The three ICD groups with the
highest number of cases were found as the followings: 1) Diseases of the muscu-
loskeletal system and connective tissue (60.74%); 2) Injury and poisoning (10.50%);
and 3) External causes of morbidity and mortality (6.29%). CONCLUSIONS: The
physiotherapy services occurred with the highest incidence in cases of the ‘dis-
eases of the musculoskeletal system and connective tissue‘ ICD group. Therefore,
authors suggest structuring the health care system and distributing resources to
follow the needs supported by our findings.
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OBJECTIVES: Home-Based Management of Malaria (HBMM) is one of the key strat-
egies to reduce the burden of malaria for vulnerable populations in endemic coun-
tries. The strategy seeks to allow caregivers to have immediate health care from
some selected and trained community members. The study sought to identify the
cost drivers of presumptive malaria treatment and cost of seeking care from the
community medicine distributors (CMDs). METHODS: A cross-sectional study was
done in the Ejisu-Juaben Municipality in the Ashanti Region. The study involved
randomly selected 400 caregivers, (10) health staff and (90) community-based med-
icine distributors (CMDs). Structured questionnaires were employed to collect
these data. Data was analyzed into descriptive statistics with SPSSS version 17
software. Test for associations were done at 95% confidence interval. RESULTS:
With the assumption that transport cost and food cost were zero (0) in HBMM, the
cost of treatment of malaria for children between 6-11 months ranged from
GH#P0.01-1.00 ( 0.19 STD), while children between the ages of 12-24 months
ranged from GH#1.00-1.50 (0.04 STD) and 36-59 months ranged from GH#2.00-3.00
(0.30 STD). Generally cost was described as affordable and drivers of treatment
cost were level of severity of the illness, distance to the homes, time spent in
traveling and in the consumer’s homes as well as the number of population within
the CMD’s catchment area. CONCLUSIONS: Cost incurred in accessing HBMM
treatment was affordable to caregivers. Drivers of treatment cost in HBMM varies
from the caregivers and care seekers.
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OBJECTIVES: Despite the fact that the overall incidence of respiratory diseases
tends to decrease, in Ukraine the prevalence of community acquired pneumonia is
high enough: in 2011 it was 494.3 per 100 thousand of the adult population. The aim
of our study was a comparative study of technology inpatient and outpatient treat-
ment of community acquired pneumonia not severe course. Clinical protocol of
Ukraine about treatment of patients with community acquired pneumonia admits
outpatient and inpatient treatment. METHODS: Using the method of cost minimi-
zation we analysed the treatment of patients with not severe community acquired
pneumonia in the course of therapeutic department (1-st group, 120 patients) and
hospital outpatient (2-nd group, 108 patients) under the supervision of physicians
outpatient department. In all cases, the treatment was successful and ended with
recovery of patients.RESULTS:The average duration of treatment of 1-st group was
9,1  1,7 days, second group - 10,4  2,0 days. Total cost of investigation and
treatment of patients in first group was €9,265.49, similar costs in second group was
€4,409.82 (1 EUR  9,98 UAH). Average direct costs of treatment per patient in first
group was €60.65, indirect costs amounted to €16.56. Total cost of treatment per
patient in first group amounted to €77.21. The total cost of treatment per patient in
second group was €40.83, of which direct costs accounted for €30.91, and indirect -
€9.93. Thus, the outpatient treatment of a patient with pneumonia were €36.38
cheaper than inpatient treatment. CONCLUSIONS: The treatment of patients with
community acquired pneumonia in hospital is more expensive than outpatient
treatment. Rise occurs both by indirect and by direct costs.
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OBJECTIVES:As Flanders (Belgium) has an average suicide rate of 1.76 times that in
the EU, prevention of suicide is important to counter the negative consequences
that are associated with suicide and suicide attempts. The objective of this study
was to evaluate the cost-effectiveness of ‘De Zelfmoordlijn’, a suicide prevention
helpline in Flanders.METHODS:An age-, gender- and medium (chat or telephone)-
dependent Markov model with a time horizon of 10 years and a 12-month cycle-
length was developed in order to predict cumulative costs and QALYs (quality
adjusted life years) in a high-risk population. Costs were taken from a societal
perspective. The model consists of six transition states: the initial phase, first non-
fatal attempt, non-fatal re-attempt, follow-up, fatal attempt and death of other
causes. A scenario with the existence of the helpline was compared with a scenario
without its existence. The effect of the helpline was derived from published liter-
ature. Uncertainty was taken into account by carrying out one-way and probabi-
listic sensitivity analysis. RESULTS: Over a period of 10 years, it is estimated that
35% of suicides and suicide attempts can be avoided in this high-risk population,
due to the suicide helpline. By means of the chat sessions and telephone service ‘De
Zelfmoordlijn’ increased average QALYs respectively by 0.057(-0.029-0.143) and
0.099 (0.050-0.148) for men and by 0.034 (-0.015-0.081) due to the telephone service
in women. The chat service led to a QALY neutral result in women (-0.002; -0.097-
0.093). The total costs decreased, resulting in net societal savings in men of €2652
(€2094-€3521) for the chat service and €2010 (€1600-€2444) for the telephone service
and in women of €1930 (€1408-€2489) and €1496 (€1116-€1910) respectively.
CONCLUSIONS: This modeling exercise predicts that ‘De Zelfmoordlijn’ is a cost-
effective, net saving, intervention to prevent suicide in a high-risk population.
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OBJECTIVES: A recent randomized controlled trial has demonstrated significant
reductions in terms of cardiovascular hospitalizations and deaths with a nurse-led
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